Warning letter
Clinical Science Laboratories Inc.: warning letter of Jul 5, 2000
FDA warning letter UCM068576 · New England District Office
Key facts
| Reference number | UCM068576 |
|---|---|
| Company | Clinical Science Laboratories Inc. |
| Subject | Drug Testing Laboratory/GMP Regulations/Laboratory Controls/Records & Rpts/Personnel Qualifications |
| Issue date | Jul 5, 2000 |
| Posted date | Jul 5, 2000 |
| Issuing office | New England District Office |
| Product type | Drugs |
| CFR sections cited | 21, 211.25, 211.160, 211.180, 211.194 |
| Country | 3 |
| Inspection city | Mansfield |
| Inspection ZIP | 02048-1511 |
| Inspection start date | May 3, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: